Cibc Private Wealth Group, LLC Haemonetics Corp Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 395 shares of HAE stock, worth $30,055. This represents 0.0% of its overall portfolio holdings.
Number of Shares
395
Previous 548
27.92%
Holding current value
$30,055
Previous $46,000
30.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$526 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$453 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$391 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$292 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$292 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.9B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...